{"DataElement":{"publicId":"2759151","version":"1","preferredName":"Neoadjuvant Immunotherapy Agent Name","preferredDefinition":"Name of a neoadjuvant immunotherapy agent administered to an individual. [Manually-curated]","longName":"NEOADJ_IMMU_AGT_NM","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2759149","version":"1","preferredName":"Neoadjuvant Therapy Immunotherapy Agent","preferredDefinition":"Treatment designed to be used as a first step toward shrinking the cancer and in evaluating response to drugs and other agents. Induction therapy is followed by additional therapy to eliminate whatever cancer remains._(IM-yoo-no-THER-a-pee) Treatment to stimulate or restore the ability of the immune system to fight infections and other diseases. Also used to lessen side effects that may be caused by some cancer treatments._An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect. (NCI)","longName":"NEOADJ_IMMU_AGT","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2759138","version":"1","preferredName":"Neoadjuvant Therapy Immunotherapy","preferredDefinition":"Treatment designed to be used as a first step toward shrinking the cancer and in evaluating response to drugs and other agents. Induction therapy is followed by additional therapy to eliminate whatever cancer remains.:(IM-yoo-no-THER-a-pee) Treatment to stimulate or restore the ability of the immune system to fight infections and other diseases. Also used to lessen side effects that may be caused by some cancer treatments.","longName":"C15665:C15262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoadjuvant Therapy","conceptCode":"C15665","definition":"Therapy administered prior to the primary treatment for the purpose of making the primary treatment more effective.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunotherapy","conceptCode":"C15262","definition":"Therapy designed to induce changes in a patient's immune status in order to treat disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F7B4540-6D25-58D5-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-12","modifiedBy":"ONEDATA","dateModified":"2008-06-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2514627","version":"1","preferredName":"Agent","preferredDefinition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect. (NCI)","longName":"C1708","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Agent","conceptCode":"C1708","definition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1BB1AAFE-FB3A-4FE3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-08-23","modifiedBy":"ONEDATA","dateModified":"2006-08-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F7C5840-A03D-125B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-12","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2758210","version":"1","preferredName":"Neoadjuvant Therapy Agent Name","preferredDefinition":"Preliminary cancer therapy (chemotherapy, radiation therapy, hormone/endocrine therapy, immunotherapy, hyperthermia, etc.) that precedes a necessary second modality of treatment._An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect._The words or language units by which a thing is known.","longName":"NEOADJ_AGT_NM","context":"NCIP","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"40","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2758209","version":"1","preferredName":"Neoadjuvant Therapy Agent Name","preferredDefinition":"Treatment designed to be used as a first step toward shrinking the cancer and in evaluating response to drugs and other agents. Induction therapy is followed by additional therapy to eliminate whatever cancer remains.:An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect. (NCI):The words or language units by which a thing is known.","longName":"C15665:C1708:C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoadjuvant Therapy","conceptCode":"C15665","definition":"Therapy administered prior to the primary treatment for the purpose of making the primary treatment more effective.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Agent","conceptCode":"C1708","definition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F53BE26-E56C-69F0-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-10","modifiedBy":"ONEDATA","dateModified":"2008-06-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F53BE26-E57D-69F0-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-10","modifiedBy":"ONEDATA","dateModified":"2008-06-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044924","version":"1","longName":"Inactive CDEs as of March 2017","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Drug(s) used","type":"Preferred Question Text","description":"Drug(s) used","url":null,"context":"NCIP"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F7C69EA-0E71-15CC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-12","modifiedBy":"TSESU","dateModified":"2018-07-16","changeDescription":"Curated to support The Cancer Genome Atlas (TCGA)  Approved for release based upon team review on 1/8/2010","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}